Showing results (11-20 of 171) with videos related to

Sort By:
Pageof 18
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 27, 2022
The immediate impact of physical function and quality of life after hematopoietic stem cell transplantationYeji Lee, Inho Kim, Youngil Koh, et al.
Blood Research|November 21, 2025
Brentuximab vedotin combined with cisplatin, cytarabine, and dexamethasone treatment in transplant-eligible Korean patients with relapsed or refractory Hodgkin's lymphomaJun Ho Yi, Young Hoon Park, Myung-Won Lee, et al.
Therapeutic Advances in Hematology|May 17, 2021
Busulfan plus melphalan <i>versus</i> melphalan alone conditioning regimen after bortezomib based triplet induction chemotherapy for patients with newly diagnosed multiple myelomaSongyi Park, Dong-Yeop Shin, Junshik Hong, et al.
Anticancer Research|May 6, 2020
Characterization and Prognosis of Secondary Acute Myeloid Leukemia in an Asian Population: AML With Antecedent Hematological Disease Confers Worst Outcomes, Irrespective of Cytogenetic RiskSheehyun Kim, Sung-Soo Yoon, Junshik Hong, et al.
In Vivo (Athens, Greece)|March 1, 2020
Importance of Monitoring Physical Function for Quality of Life Assessments in Hematopoietic Stem Cell Transplantation Patients: A Prospective Cohort StudyInho Kim, Youngil Koh, Dongyeop Shin, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 3, 2025
Concurrence of prothrombin nonneutralizing antibody and factor XI neutralizing inhibitor in lupus anticoagulant positive patientJu Hyeong Lee, Ja-Yoon Gu, Junshik Hong, et al.
Cytotherapy|April 2, 2026
Role of salvage allogeneic transplantation for relapsed or refractory AML in nonremission: insights from real-world practiceSeungah Cha, Dong-Yeop Shin, Junshik Hong, et al.
Therapeutic Advances in Hematology|January 6, 2022
Association between preconditioning absolute lymphocyte count and transplant outcomes in patients undergoing matched unrelated donor allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning and anti-thymocyte globulinJeongmin Seo, Dong-Yeop Shin, Youngil Koh, et al.
Journal of Clinical Medicine|July 29, 2020
Allogeneic Stem Cell Transplantation in Relapsed/Refractory Multiple Myeloma Treatment: Is It Still Relevant? (Running Title: The Role of Salvage alloSCT in MM)Hyunkyung Park, Ja Min Byun, Sung-Soo Yoon, et al.
Oncology Letters|September 20, 2021
Pan-RAF inhibitor LY3009120 is highly synergistic with low-dose cytarabine, but not azacitidine, in acute myeloid leukemia with <i>RAS</i> mutationsJihyun Park, Hyejoo Park, Ja Min Byun, et al.
Pageof 18